Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03620318
Title Individual Patient Compassionate Use of Crenolanib
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Arog Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

Crenolanib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST